Elli Kaplan is Co-founder and CEO of Neurotrack, a digital health company dedicated to the development of a digital cognitive assessment test that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline and help advance research and treatment of cognitive diseases like Alzheimer’s. Neurotrack is also building a cognitive health product that brings together the best scientific research shown to reduce the risk of cognitive decline and improve overall cognitive health.

Elli has two decades of experience in the public and private sectors, including positions at the White House, the State and Treasury Departments, and the United Nations Development Program. She also held positions with AIG, Goldman Sachs and multiple startups, and has an M.B.A. from Harvard.